GEDI Act

Bill: 111-hr-5354
Sponsor: Rep. Engel, Eliot L. [D-NY-17]
Introduced: 2010-05-20 in the House
Policy area: Health
Subjects: Advisory bodies
Digestive and metabolic diseases
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Medical research
Medical tests and diagnostic methods
Sex and reproductive health
Women's health

Summary:
action_date: 2010-05-20
text: 
 Gestational Diabetes Act of 2009 

[
sic
] or the GEDI Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to convene a Research Advisory Committee. Requires the Director, in consultation with the Research Advisory Committee, to develop a multisite, gestational diabetes research project within the CDC's diabetes program to expand and enhance surveillance data and public health research on gestational diabetes. 
 
Requires the Secretary, acting through the Director, to award grants to nonprofit organizations or state or local health agencies for demonstration projects that build capacity with key stakeholders, build new surveillance systems, and implement and evaluate evidence-based interventions to reduce the incidence of gestational diabetes and its recurrence and to prevent type 2 diabetes after pregnancy.
 
Requires the Director to conduct and support public health research regarding gestational diabetes, which research shall include: (1) developing and testing novel approaches for improving postpartum diabetes testing or screening and for preventing type 2 diabetes in women with a history of gestational diabetes; and (2) conducting research to further understanding of the epidemiologic, socioenvironmental, behavioral, translation, and biomedical factors and health systems that influence risk of gestational diabetes and progression to type 2 diabetes.
 
Requires the Director to encourage postpartum screenings after gestational diabetes within the state-based diabetes prevention and control programs to reduce the incidence of gestational diabetes and its recurrence, progression to type 2 diabetes, and its related complications.
 

action_date: 2010-09-30
text: 
Gestational Diabetes Act of 2010 or the GEDI Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to develop a multisite gestational diabetes research project within the diabetes program of the CDC to expand and enhance surveillance data and public health research on gestational diabetes. Requires such research project to address: (1) procedures to establish accurate and efficient systems for the collection of gestational diabetes data; (2) the progress of collaborative activities with the National Vital Statistics System, the National Center for Health Statistics, and state health departments to improve surveillance of gestational diabetes; (3) postpartum methods of tracking women with gestational diabetes after delivery and targeted interventions to lower the incidence of type 2 diabetes in such women; (4) variations in the distribution of diagnosed and undiagnosed gestational diabetes; and (5) factors and culturally sensitive interventions that influence risks and reduce the incidence of gestational diabetes and related complications during childbirth. Requires the Secretary, not later than two years after the enactment of this Act, to report on the findings and recommendations of the research project. 
 
Requires the Secretary to expand and intensify public health research on gestational diabetes, including; (1) developing and testing novel approaches for improving postpartum testing or screening and for preventing type 2 diabetes in women with a history of gestational diabetes; and (2) conducting research to further understanding of the factors and health systems that influence the risk of gestational diabetes and the development of type 2 diabetes in women with a history of gestational diabetes. 
 
Requires the Secretary, acting through the Director of the CDC, to: (1) award grants on a competitive basis for demonstration projects that implement evidence-based interventions to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) report to Congress, not later than four years after the enactment of this Act, on the results of the demonstration projects. Sets forth priorities for awarding grants and requirements for the use of grant funds for carrying out demonstration projects.
 
Requires the Secretary, acting through the Director of the CDC, to work with state and Indian tribal-based diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and related complications.
 
Authorizes appropriations for FY2012-FY2016.


Legislative actions:
action_date: 2010-11-15
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2010-09-30
text: The title of the measure was amended. Agreed to without objection.
action_date: 2010-09-30
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2010-09-30
text: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR 9/28/2010 H7178-7179)
action_date: 2010-09-30
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR 9/28/2010 H7178-7179)
action_date: 2010-09-30
text: Considered as unfinished business. (consideration: CR H7379)
action_date: 2010-09-28
text: At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Burgess objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was withdrawn.
action_date: 2010-09-28
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 5354.
action_date: 2010-09-28
text: Considered under suspension of the rules. (consideration: CR H7178-7180)
action_date: 2010-09-28
text: Mr. Pallone moved to suspend the rules and pass the bill, as amended.
action_date: 2010-09-28
text: Placed on the Union Calendar, Calendar No. 373.
action_date: 2010-09-28
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 111-633.
action_date: 2010-09-28
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 111-633.
action_date: 2010-09-23
text: Ordered to be Reported (Amended) by Voice Vote.
action_date: 2010-09-23
text: Committee Consideration and Mark-up Session Held.
action_date: 2010-09-16
text: Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
action_date: 2010-09-16
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2010-09-15
text: Subcommittee Hearings Held.
action_date: 2010-05-21
text: Referred to the Subcommittee on Health.
action_date: 2010-05-20
text: Referred to the House Committee on Energy and Commerce.
action_date: 2010-05-20
text: Introduced in House
action_date: 2010-05-20
text: Introduced in House